No retraction, correction or concern found when last checked on Nov 1, 2026.
Coronavirus vaccine development: from SARS and MERS to COVID-19
Yen-Der Li, Wei-Yu Chi, Jun-Han Su and 3 more
Journal of Biomedical Science · 2020 · Review · CC BY
doi:10.1186/s12929-020-00695-2
Abstract
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a new type of coronavirus that causes the Coronavirus Disease 2019 (COVID-19), which has been the most challenging pandemic in this century. Considering its high mortality and rapid spread, an effective vaccine is urgently needed to control this pandemic. As a result, the academia, industry, and government sectors are working tightly together to develop and test a variety of vaccines at an unprecedented pace. In this review, we outline the essential coronavirus biological characteristics that are important for vaccine design. In addition, we summarize key takeaways from previous vaccination studies of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV), highlighting the pros and cons of each immunization strategy. Finally, based on these prior vaccination experiences, we discuss recent progress and potential challenges of COVID-19 vaccine development.
Cited by papers we hold 7
- Circular RNA vaccine in disease prevention and treatment · 2023No notice
- Association of Online Search Trends With Vaccination in the United States: June 2020 Through May 2021 · 2022Not checked
- COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection · 2022No notice
- SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants · 2021No notice
- «SCORE-CoV-2» y su relación con el comportamiento del PIB · 2021Not checked
- A colloidal gold-based immunochromatographic strip for rapid detection of SARS-CoV-2 antibodies after vaccination · 2021Not checked
- Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination · 2021No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.